VIGILANT
Research type
Research Study
Full title
naVIGation Invitations Liver surveillANce upTake
IRAS ID
335338
Contact name
R Sharma
Contact email
Sponsor organisation
Imperial College London
Duration of Study in the UK
3 years, 6 months, 0 days
Research summary
This is a single site Open label two arm randomised control trial of 652 participants to describe the efficacy of patient navigators for attendance at HCC (Hepatology Carcinoma) surveillance.
Patients with cirrhosis or chronic liver disease will be eligible for HCC surveillance. A waiver of consent will be sought form the ethics board to reduce volunteer bias, which otherwise would threaten the generalisability and validity of findings as a population health study.
A patient navigator will provide scripted phone calls before appointments and if patients do not attend to re-book and/discuss barrier for non-attendance.
The study duration would be 3.5 years.
REC name
North of Scotland Research Ethics Committee 2
REC reference
24/NS/0068
Date of REC Opinion
18 Jun 2024
REC opinion
Unfavourable Opinion